Whole Muscle Exercise Training (WHOLEi+12) in Pulmonary Hypertension
WHOLEi+12
Exercise Training (WHOLEi+12) in Pulmonary Hypertension
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this RCT is to study the effects of whole muscle training (inspiratory muscle training + aerobic training + muscle resistance training) on muscle power, VO2peak and gas-exchange variables obtained during cardiopulmonary exercise testing, QoL, functional capacity (eg, 6-min walking distance), and maximal inspiratory pressure in patients with pulmonary artery hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2014
CompletedFirst Posted
Study publicly available on registry
November 11, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJuly 19, 2016
July 1, 2016
1.4 years
November 5, 2014
July 18, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Muscle power (upper and lower-body)
8 weeks
Secondary Outcomes (9)
6 minute walk distance test
8 weeks
maximal inspiratory pressure (PImax)
8 weeks
Short Form 36-Item Health Survey questionnaire version 2 (SF-36)
8 weeks
Physical activity levels objectively determined with accelerometry
8 weeks
Peak oxygen uptake (VO2peak) directly measured during cardiopulmonary exercise testing (CEPT)
8 weeks
- +4 more secondary outcomes
Study Arms (2)
control
NO INTERVENTIONexercise
EXPERIMENTALexercise intervention during 8 weeks
Interventions
Exercise training for 8 weeks (aerobic exercise, resistance training and inspiratory muscle training thrice a week)
Eligibility Criteria
You may qualify if:
- Diagnosed pulmonary hypertension, class II-III NYHA, no syncope in the last 3 months (stable clinical condition) or chronic thromboembolic pulmonary hypertension
You may not qualify if:
- Not meeting the above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital 12 de Octubre
Madrid, Madrid, 28041, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
November 5, 2014
First Posted
November 11, 2014
Study Start
January 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
July 19, 2016
Record last verified: 2016-07